Samuel R Saks Protagonist Therapeutics, Inc (PTGX) insider trading activity
Samuel R Saks is Chief Medical Officer of Protagonist Therapeutics, Inc. Currently has a direct ownership of 14,000 shares of PTGX, which is worth approximately $588,280. The most recent transaction as insider was on Feb 26, 2021, when has been sold 12,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14K
0%
3M change
0%
12M change
Total Value Held
$588,280
SRS
Samuel R Saks
Chief Medical Officer
Newark, CA